How reliable is an effective orifice area indexed chart?
- PMID: 20099694
How reliable is an effective orifice area indexed chart?
Abstract
Background and aim of the study: Patient-prosthesis mismatch (PPM) occurs when a valvular prosthesis is too small relative to the patient's body surface area (BSA). The presence of PPM results in increased transprosthetic gradients and may portend a worse prognosis. It has been shown that reliable effective orifice area (EOA) data can be used to accurately predict PPM, thus preventing its occurrence. The study aim was to assess the predictive abilities of an effective orifice area indexed (EOAI) chart--the Perimount Magna EOAI chart--in the prevention of PPM.
Methods: A retrospective comparison of projected versus calculated EOA values and the predicted versus actual incidence of PPM was conducted. Forty patients with a Perimount Magna aortic bioprosthesis implanted between 1st January 2006 and 31st March 2009, were identified. The sensitivity, specificity, positive-predictive value (PPV) and negative predictive value (NPV) were each calculated using the Perimount Magna EOAI chart, to assess how well it could predict the incidence of postoperative PPM.
Results: The Perimount Magna EOAI chart had a sensitivity of 35% for predicting postoperative PPM, and an NPV of 53%. The projected EOA-values were almost invariably larger than those actually measured; this resulted in a higher proportion of patients than in whom PPM was predicted preoperatively. This EOAI chart proved to be very specific, with specificity of 100% and a PPV of 100%.
Conclusion: The Perimount Magna EOAI chart, based on mean EOA data from a small echocardiographic cohort, represents a poor method of predicting and preventing PPM. Rather, EOAI charts should be based on reliable EOA data that reproducibly predict the expected EOA for that prosthesis.
Similar articles
-
The effective orifice area/patient aortic annulus area ratio: a better way to compare different bioprostheses? A prospective randomized comparison of the Mosaic and Perimount bioprostheses in the aortic position.J Heart Valve Dis. 2004 May;13(3):382-8; discussion 388-9. J Heart Valve Dis. 2004. PMID: 15222284 Clinical Trial.
-
[Avoidance of patient-prosthesis mismatch].Kyobu Geka. 2006 Apr;59(4):262-8. Kyobu Geka. 2006. PMID: 16613142 Japanese.
-
Hemodynamic performance and incidence of patient-prosthesis mismatch of the complete supraannular perimount magna bioprosthesis in the aortic position.Thorac Cardiovasc Surg. 2005 Aug;53(4):226-30. doi: 10.1055/s-2005-837678. Thorac Cardiovasc Surg. 2005. PMID: 16037868 Clinical Trial.
-
Limitations in the Assessment of Prosthesis-Patient Mismatch.Thorac Cardiovasc Surg. 2020 Oct;68(7):550-556. doi: 10.1055/s-0038-1676814. Epub 2019 Jan 4. Thorac Cardiovasc Surg. 2020. PMID: 30609446
-
Manufacturer-provided effective orifice area index charts and the prevention of prosthesis-patient mismatch.J Heart Valve Dis. 2012 Jan;21(1):107-11. J Heart Valve Dis. 2012. PMID: 22474751 Review.
Cited by
-
Prosthesis-patient mismatch - what cardiac anesthesiologists need to know?Ann Card Anaesth. 2017 Apr-Jun;20(2):234-242. doi: 10.4103/aca.ACA_9_17. Ann Card Anaesth. 2017. PMID: 28393786 Free PMC article. Review.
-
Prosthesis-patient mismatch in aortic stenosis.Gen Thorac Cardiovasc Surg. 2014 Feb;62(2):78-86. doi: 10.1007/s11748-013-0331-4. Epub 2013 Oct 17. Gen Thorac Cardiovasc Surg. 2014. PMID: 24132681 Review.
-
The fallacy of indexed effective orifice area charts to predict prosthesis-patient mismatch after prosthesis implantation.Eur Heart J Cardiovasc Imaging. 2020 Oct 1;21(10):1116-1122. doi: 10.1093/ehjci/jeaa044. Eur Heart J Cardiovasc Imaging. 2020. PMID: 32243493 Free PMC article.
-
Magna ease bioprosthetic aortic valve: mid-term haemodynamic outcomes in 1126 patients.Interact Cardiovasc Thorac Surg. 2021 May 27;32(6):839-845. doi: 10.1093/icvts/ivab016. Interact Cardiovasc Thorac Surg. 2021. PMID: 33570145 Free PMC article.
MeSH terms
LinkOut - more resources
Research Materials